Scientists discover that thyroid cancer cells become less aggressive in outer space

For those who think that space exploration offers no tangible benefits for those of us on earth, a new research discovery involving thyroid cancer may prove otherwise. In a new report appearing in the February 2014 issue of The FASEB Journal, researchers from Germany and Denmark show that some tumors which are aggressive on earth are considerably less aggressive in microgravity. By understanding the genetic and cellular processes that occur in space, scientists may be able to develop treatments that accomplish the same thing on earth.

"Research in space or under simulated microgravity using ground-based facilities helps us in many ways to understand the complex processes of life and this study is the first step toward the understanding of the mechanisms of cancer growth inhibition in microgravity," said Daniela Gabriele Grimm, M.D., a researcher involved in the work from the Department of Biomedicine, Pharmacology at Aarhus University in Aarhus, Denmark. "Ultimately, we hope to find new cellular targets, leading to the development of new anti-cancer drugs which might help to treat those tumors that prove to be non-responsive to the currently employed agents."

To make their discovery, Grimm and colleagues used the Science in Microgravity Box (SIMBOX) experimental facility aboard Shenzhou-8, which was launched on October 31, 2011. Cell feeding was automatically performed in space on day five and automated cell fixation was conducted on day 10. Inflight control was achieved by using a centrifuge in space. On November 17, 2011, Shenzhou-8 landed and the experimental samples were analyzed. Additional cells were analyzed using a random positioning machine which aims to achieve simulated microgravity conditions on the ground by rotating a sample around two axes operated in a random real direction mode. Both cell types were investigated with respect to their gene expression and secretion profiles, employing modern molecular biological techniques, such as whole genome microarrays and multi-analyte profiling. Results suggested that the expression of genes indicating a high malignancy in cancer cells may be down-regulated under altered gravitational stimulation.

"We are just at the beginning of a new field of medicine that studies the effects of microgravity on cell and molecular pathology. Space flight affects our bodies, both for good and bad," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "We've known that microgravity can cause some microorganisms to become more virulent and that prolonged has negative effects on the human body. Now, we learn that it's not all bad news: what we learn from cells in should help us understand and treat malignant tumors on the ground."

More information: Xiao Ma, Jessica Pietsch, Markus Wehland, Herbert Schulz, Katrin Saar, Norbert Hübner, Johann Bauer, Markus Braun, Achim Schwarzwälder, Jürgen Segerer, Maria Birlem, Astrid Horn, Ruth Hemmersbach, Kai Waßer, Jirka Grosse, Manfred Infanger, and Daniela Grimm. Differential gene expression profile and altered cytokine secretion of thyroid cancer cells in space. FASEB J. February 2014 28:813-835; DOI: 10.1096/fj.13-243287

Related Stories

NASA preps for space-based stem cell research

Dec 09, 2013

NASA and the Center for the Advancement of Science in Space (CASIS) are enabling research aboard the International Space Station that could lead to new stem cell-based therapies for medical conditions faced on Earth and in ...

Space-raised flies show weakened immunity to fungus

Jan 24, 2014

Venturing into space might be a bold adventure, but it may not be good for your immune system. Now a study by researchers at the University of California, Davis and published Jan. 24 in the journal PLOS ON ...

Fighting cancer with microgravity research

Jun 25, 2013

(Phys.org) —For lab-coated cancer biologists, peering through microscopes at stained tissue samples under fluorescent lights, the International Space Station may be the last thing that comes to mind. But ...

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.